Nanobiotix S.A. (NBTX)
NASDAQ: NBTX
· Real-Time Price · USD
9.35
0.82 (9.61%)
At close: Aug 20, 2025, 3:53 PM
Nanobiotix S.A. Income Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Revenue | -11.61M | 42.2M | 36.21M | 5.02M | 2.39M | 1.33M | 674K | 23K |
Cost of Revenue | n/a | n/a | n/a | 754K | 1.5M | 1.5M | 109.5K | -1.07M |
Gross Profit | -11.61M | 42.2M | 36.21M | 4.26M | 888K | -176.5K | 564.5K | 1.1M |
Operating Income | -68.39M | -25.06M | -26.78M | -49.62M | -50.49M | -50.38M | -49.8M | -44.77M |
Interest Income | 2.63M | n/a | n/a | 250K | 1.61M | 2.58M | 2.78M | 2.58M |
Pretax Income | -68.03M | -33.21M | -39.58M | -61.81M | -61.12M | -45.25M | -49.49M | -45.69M |
Net Income | -68.13M | -33.47M | -39.7M | -58.78M | -57.04M | -42.94M | -47M | -43.43M |
Selling & General & Admin | 20.06M | 22.02M | 22.05M | 18.85M | 17.48M | 18.51M | 19.02M | 17.73M |
Research & Development | 40.54M | 42.58M | 38.4M | 33.34M | 31.47M | 30.29M | 29.23M | 25.43M |
Other Expenses | -3.82M | 2.67M | 2.54M | 19K | -43K | -68K | n/a | 12K |
Operating Expenses | 56.78M | 67.27M | 62.99M | 52.16M | 48.99M | 48.87M | 48.25M | 43.14M |
Interest Expense | 8.09M | n/a | n/a | 3.11M | 3.11M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 56.78M | 67.27M | 62.99M | 52.91M | 50.49M | 50.38M | 49.81M | 44.79M |
Income Tax Expense | 101K | 261K | 120K | -3.03M | -4.08M | -2.31M | -2.49M | -2.26M |
Shares Outstanding (Basic) | 47.27M | 47.12M | 37.99M | 35.04M | 34.85M | 34.84M | 34.81M | 34.62M |
Shares Outstanding (Diluted) | 47.27M | 47.12M | 38.82M | 35.04M | 34.85M | 34.84M | 34.81M | 34.62M |
EPS (Basic) | -1.44 | -0.76 | -1.1 | -1.68 | -1.64 | -1.24 | -1.36 | -1.35 |
EPS (Diluted) | -1.44 | -0.77 | -1.11 | -1.68 | -1.64 | -1.24 | -1.36 | -1.35 |
EBITDA | -58.32M | -21.83M | -23.22M | -34.9M | -22.35M | -22.64M | -22.34M | -19.92M |
EBIT | -59.95M | -22.39M | -24.24M | -35.78M | -22.86M | -23.86M | -23.58M | -21.3M |
Depreciation & Amortization | 1.62M | 561K | 1.01M | 1.5M | 1.5M | 1.5M | 1.56M | 1.65M |